Peer Reviewed Published Study
Pilot Study: Autologous platelet‐rich plasma used in a topical cream for facial rejuvenation. A 60-day, 20 subject split face, blinded study demonstrated enhanced softness, brightness, luminosity, firmness at four weeks with a more robust performance at eight weeks, as assessed by both the investigator and study subjects.
Leading the market, Aesthetics Biomedical® Inc. (ABM) has developed a personalized take-home topical Platelet Rich Plasma (PRP) cosmetic product, supported by clinical results. ABM is proud to introduce SoME® Skincare to the clinical community for point of care physician use.
Cover Feature of THE Aesthetic Guide x SoME™ Skincare featuring Brand Ambassador Molly Sims
Six Page Editorial: Groundbreaking PRP-Based Home Skincare Revolutionizes the Industry
Dr. Michael DeWolfe
Dr. Sejal Shah
Dr. Diane Quibell
Lawerence Rheins PhD
SoME® Skincare Overview
The overview deck of SoME® Skincare consists of scientific data, clinical study outcomes, patient satisfaction, key features, marketing support, and market opportunity.
Until now, there has never been an autologous topical skincare product backed by dermatologists with proven results. SoME® Skincare+ PRP uses the body’s own regenerative properties to stimulate natural collagen and elastin for visibly renewed firmness and luminosity.
Vivace® Microneedle RF:
Learn more about Vivace® Microneedle RF – an exciting, best-in-class, proprietary treatment.
Demand for microneedling surges. Microneedling is one of the top ten, most searched topics in aesthetics. Microneedling (also known as collagen induction therapy) is a minimally invasive treatment to rejuvenate the skin.
The Vivace® utilizes RF and microneedling to gently heat the targeted area underneath the epidermis for optimal results, less pain, and minimal downtime. The Vivace® dramatically improves treatment outcomes and is much more affordable to acquire and operate.
Read what physicians are saying about the Vivace Experience®.
“This is a great device. In terms of ROI at my practice, we’ve never had a device launch this successfully. —Dr. Emil Tanghetti, Sacramento, CA